Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Cancers
|
May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain
David Zahrieh, Daniel Satele, Hiboombe Haamankuli, et al.
Breast Cancer Research and Treatment
|
February 14, 2009
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
Stephanie L Hines, Betty Mincey, Todor Dentchev, et al.
Menopause (New York, N.Y.)
|
September 9, 2011
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7
Sandhya Pruthi, Rui Qin, Shelby A Terstreip, et al.
JAMA Oncology
|
December 9, 2021
Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial
Alyx B Porter, Heshan Liu, Sadhna Kohli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Saranya Chumsri, Jeff Sperinde, Heshan Liu, et al.
The Oncologist
|
June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)
Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 14, 2021
The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial
Marie E Wood, Heshan Liu, Elizabeth Storrick, et al.
Cancer
|
October 20, 2020
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients
Michelle J Naughton, Heshan Liu, Drew K Seisler, et al.
Cancer
|
October 20, 2020
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)
Electra D Paskett, Jennifer Le-Rademacher, Jill M Oliveri, et al.
European Urology Focus
|
May 3, 2022
Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
J Kellogg Parsons, David Zahrieh, Devin Patel, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Cancers
|
May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain
David Zahrieh, Daniel Satele, Hiboombe Haamankuli, et al.
Breast Cancer Research and Treatment
|
February 14, 2009
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
Stephanie L Hines, Betty Mincey, Todor Dentchev, et al.
Menopause (New York, N.Y.)
|
September 9, 2011
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7
Sandhya Pruthi, Rui Qin, Shelby A Terstreip, et al.
JAMA Oncology
|
December 9, 2021
Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial
Alyx B Porter, Heshan Liu, Sadhna Kohli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Saranya Chumsri, Jeff Sperinde, Heshan Liu, et al.
The Oncologist
|
June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)
Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 14, 2021
The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial
Marie E Wood, Heshan Liu, Elizabeth Storrick, et al.
Cancer
|
October 20, 2020
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients
Michelle J Naughton, Heshan Liu, Drew K Seisler, et al.
Cancer
|
October 20, 2020
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)
Electra D Paskett, Jennifer Le-Rademacher, Jill M Oliveri, et al.
European Urology Focus
|
May 3, 2022
Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
J Kellogg Parsons, David Zahrieh, Devin Patel, et al.
Page
of 7